Olema Pharmaceuticals (OLMA) PT Raised to $38 at Goldman Sachs
Tweet Send to a Friend
Goldman Sachs analyst Richard Law raised the price target on Olema Pharmaceuticals (NASDAQ: OLMA) to $38.00 (from $26.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
